# Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia

> **NCT00943306** · PHASE3 · COMPLETED · sponsor: **Aegerion Pharmaceuticals, Inc.** · enrollment: 19 (actual)

## Conditions studied

- Familial Hypercholesterolemia

## Interventions

- **DRUG:** lomitapide

## Key facts

- **NCT ID:** NCT00943306
- **Lead sponsor:** Aegerion Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10-29
- **Primary completion:** 2012-09-17
- **Final completion:** 2014-12-01
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2018-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00943306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00943306, "Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00943306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*